2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Phase III study comparing bevacizumab plus erlotinib to erlotinib in patients with untreated NSCLC harboring activating EGFR mutations: NEJ026.

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Journal of Clinical Oncology
          JCO
          American Society of Clinical Oncology (ASCO)
          0732-183X
          1527-7755
          May 20 2018
          May 20 2018
          : 36
          : 15_suppl
          : 9006
          Affiliations
          [1 ]Division of Respiratory Medicine, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan;
          [2 ]Department of Respiratory Medicine, Miyagi Cancer Center, Natori, Japan;
          [3 ]Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan;
          [4 ]Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Japan;
          [5 ]Department of Medical Oncology, Chiba University Hospital, Chiba, Japan;
          [6 ]Department of General Thoracic Surgery, Ishikawa Prefectural Central Hospital, Kanazawa, Japan;
          [7 ]Department of Respiratory Medicine, Saitama Medical University International Medical Center, Hidaka, Japan;
          [8 ]Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan;
          [9 ]Clinical Cancer Center, Fukujuji Hospital, JATA, Tokyo, Japan;
          [10 ]Pulmonary Division, Internal Medicine, Saiseikai Utsunomiya Hospital, Utsunomiya, Japan;
          [11 ]Department of Pulmonary Medicine and Oncology, Nippon Medical School, Tokyo, Japan;
          [12 ]Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan;
          [13 ]Division of Pulmonary Medicine, Department of Internal Medicine, Jichi Medical University, Shimotsuke, Japan;
          [14 ]Department of Respiratory Medicine, Tohoku University, Sendai, Japan;
          [15 ]Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan;
          [16 ]Iwate Medical University, Morioka, Japan;
          Article
          10.1200/JCO.2018.36.15_suppl.9006
          fe24008d-3b09-4e47-881c-2d82d65acb61
          © 2018
          History

          Comments

          Comment on this article